The aim of this study was to develop a novel predictive medium-throughput screening method for drug permeability, with use of a tight barrier of liposomes on a filter support. To our knowledge no one has succeeded in depositing membrane barriers without the use of inert solvent such as hexadecane. The first part of the study involved development of a protocol for preparation of these barriers, which were made of liposomes from egg phosphatidylcholin in phosphate buffer pH 7.4 with 10 % (v/v) ethanol. The liposomes were deposited into the pores and onto the surface of a filter support (mixed cellulose ester) by use of centrifugation.
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The aim of this study was to develop a novel predictive medium-throughput screening method for drug permeability, with use of a tight barrier of liposomes on a filter support. To our knowledge no one has succeeded in depositing membrane barriers without the use of inert solvent such as hexadecane. The first part of the study involved development of a protocol for preparation of these barriers, which were made of liposomes from egg phosphatidylcholin in phosphate buffer pH 7.4 with 10 % (v/v) ethanol. The liposomes were deposited into the pores and onto the surface of a filter support (mixed cellulose ester) by use of centrifugation.
Solvent evaporation and freeze-thaw cycling were then used to promote fusion of liposomes and a tight barrier could be obtained as shown with calcein permeability and electrical resistance. In the second part of the study the model was validated using 21 drug compounds, which cover a wide range of physicochemical properties and absorption (F a ) in humans (13-100%). The drug permeation studies were carried out at room temperature with phosphate buffer (pH 7.4) in both acceptor and donor chambers. The apparent permeability coefficients obtained from the phospholipid vesicle based model correlated well with literature data on human absorption in vivo, which suggests that its performance is adequate and that the method is suitable for rapid screening of passive transport of new chemical entities. The results obtained from our model were compared with polar surface area (PSA) and experimental log D and results obtained by established permeability screening methods such as immobilised liposome chromatography (ILC), the PAMPA models and the Caco-2 model.
Our approach seems to model the in vivo absorption better than PSA, experimental log D, the ILC and PAMPA models, when similar conditions are used as in our assay, and equally well as the Caco-2 model and the Double Sink PAMPA (DS-PAMPA) model. Keywords: Artificial membrane, prediction, oral absorption, PAMPA, Caco-2 model, immobilized liposome chromatography (ILC), PSA, passive diffusion, permeability classification, liposome, intestinal absorption, phospholipid
Introduction
The increasing awareness of the importance of ADME-screening (absorption distribution metabolism excretion) of potential drug candidates already in early drug discovery has encouraged strong efforts in the development of rapid and reliable screening tools (Hidalgo, 2001 ; Kariv et al., 2002; Kerns and Di, 2003; Lipinski et al., 1997; Smith and van de Waterbeemd, 1999; van de Waterbeemd et al., 2001 ). Both in silico and experimental methods are available today for prediction and/or screening of properties related to oral drug absorption. Many of the experimental cell-based techniques, e.g. the Caco-2 monolayer model, give reliable results, but are too complicated and time-consuming to fit in a true highthroughput format. Among the most used techniques today for rapid screening are the PAMPA (parallel artificial membrane permeation assay) (Avdeef, 2003; Kansy et al., 2004; Wohnsland and Faller, 2001 ) and the ILC (immobilized liposome chromatography) methods (Beigi et al., 1995; Liu et al., 2002; Lundahl and Beigi, 1997) . PAMPA uses a simple phospholipid/organic solvent-coated filter as the permeability barrier, which allows for medium-to high-throughput screening of permeability properties. ILC is basically an HPLC-method by which the drug-membrane interaction is studied as differences in retention times on columns covered with immobilized liposomes. The throughput of this method is mainly limited by the analytical method used (HPLC). Such simplified permeability approaches do not model paracellular or active transport pathways. However, recent reports conclude that 80-95% of commercial drugs are absorbed primarily by passive diffusion (Mandagere et al., 2002) . Therefore a model merely monitoring passive diffusion appears useful as a first step in biopharmaceutical characterisation of new chemical entities.
We have developed a novel approach for measuring steady-state drug permeability using a permeation barrier made of a tight layer of phospholipid vesicles. This barrier is advantageous to the permeation barrier used in PAMPA and ILC as it appears to mimic the in vivo situation better or at least equally well in terms of predicting fraction absorbed in humans after oral administration (Fa). In addition, the method is easy to use and gives highly reproducible results. It is presently designed for a medium-throughput format but can easily be extended for use in rapid screening of large number of compounds. The method has been validated using a series of drugs covering a broad range of physicochemical properties and absorption properties upon oral administration in humans.
Experimental section

Materials
Egg phosphatidyl choline, Lipoid E-80 was obtained from Lipoid, Germany. Alprenolol hydrochloride, atenolol, acebutolol hydrochloride, caffeine, chloramphenichol, chlorothiazide, enalapril maleate, hydrochlorothiazide, metoprolol tartrate, nadolol, ranitidine hydrochloride, sulphasalazine, sulpiride, testosterone, terbutaline hemisulfate, timolol maleate, tranexamic acid, calcein and 2',7'-dichlorofluorescein were purchased from Sigma-Aldrich Co, St. Louis, USA. Amiloride hydrochloride and fluorescein sodium were supplied by Merck KGaA, Darmstadt, Germany. Salicylic acid and acetyl salicylic acid were obtained from NMD, Oslo, Norway. Cimetidine and 5(6)-carboxyfluorescein were purchased from Allphamed Pharma GmbH, Göttingen, Germany, and Fluka Chemie AG, Buchs, Switzerland, respectively.
Culture inserts (Transwell-Clear, d = 6.5 mm) and plates were purchased from Corning Inc, Corning, USA, the existing filter removed and the mixed cellulose ester filters from Millipore, Billerica, USA fused on.
Preparation of vesicular phospholipid barriers 1
The present technique essentially involves deposition of liposomes, prepared by film hydration/filter-extrusion, on filter supports in culture inserts, to obtain a barrier for transport studies. Egg phosphatidyl choline (1.8 g) was dissolved in a mixture of chloroform and methanol (2:1) (6 mL) in a round bottom flask. The organic solvent was removed under vacuum at 55 o C. The deposited lipid film was exposed to vacuum of 55 hPa at room temperature for an additional period of 3 hr to remove traces of solvent, before hydration with phosphate buffer [KH 2 PO 4 (0.3 g); Na 2 HPO 4 x 12H 2 O (3.2g); NaCl (3.62g); NaN 3 (0.1 g);
water to 500 mL; pH adjusted to 7.4 by HCl/NaOH] containing 10 % (v/v) ethanol to obtain a 6 % (w/v) liposomal dispersion.
The liposome dispersion was then filter-extruded through 0.8 and 0.4 µm polycarbonate membrane filters (Millipore) at room temperature. The extrusion was done by hand with a syringe through the filters in a 25 mm Swinnex ® Filter Holder from Millipore. To obtain liposomes of two different sizes one portion was extruded five times through the 0. 2 Scanning electron microscope (Jsm-6300 from JEOL, Japan) pictures of the mixed cellulose ester filter, magnified 10000 times is given in Figure C in the Supplementary material.
Test compounds
The drug substances chosen to validate the phospholipid vesicle based membrane model cover a wide range of physicochemical properties (molecular weight, pKa, log D and hydrogen bonding properties, see Table 1 ) and a broad range of fraction absorbed after oral administration in humans (F a = 13-100 %). The 21 chosen drugs along with the concentration of stock solutions and the wavelengths used for UV analysis are listed in Table A These four dyes were selected, as they are hydrophilic and relatively low in molecular mass (~350-650 Da) and hence would give an indication of potential aqueous pathways in the lipid barrier. Table 1 Stock solutions of the test compounds were prepared by dissolving the drug in phosphate buffer pH 7.4 on a sonication bath (Branson 1510, Branson Ultrasonic B.V., The Netherlands) followed by filtration through 0.22 μm filter (Millex-GS, Millipore, USA) and pH adjustment with HCl/NaOH to 7.4 if necessary. The concentrations of the different drug solutions (see Table A , Supplementary material) were chosen by analytical considerations as well as to obtain the sink conditions during the permeation studies. The concentration of the different drug solutions had to be high enough that the amount of drug in the acceptor chambers during permeation studies could be quantified by means of UV-absorbance, and still be below the solubility limits.
Permeation studies
Permeation studies were performed after loading the inserts with drug solution (100 μL) and placing them in separate acceptor compartments containing phosphate buffer (600 μL) (pH 7.4) (see Figure 2 ). The permeation experiment was carried out at room temperature without agitation and inserts were moved to wells containing an equal quantity of fresh buffer at 1 hr intervals for the first 3 hr and 0.5 hr interval for the next 2 hr of study. [nmol/mL], respectively. The experiments were performed under sink conditions, i.e. the drug concentration in the acceptor chamber did not exceed 10 % of the drug concentration in the donor chamber at any time (Artursson, 1990) . By using sink conditions, the influence of drug diffusing back from the acceptor to the donor chamber could be minimized and the concentration of solution in the acceptor chamber was considered small and neglected for calculation purposes. The equation could thus be simplified to: liposomes of a size corresponding to the pore size of the filters used (Berger et al., 2001 ). The use of repeated extrusion cycles through the same filter pore size has also been shown to reduce the liposome size (Hope et al., 1993) . The presence of ethanol in the hydrated phospholipids, in the concentrations used in this study, has also been shown to result in liposome formation (Polozova et al., 2005) . Aqueous phospholipid dispersions of equally high concentration as that of the deposited layer in the current studies, have previously been described as "vesicular phospholipid gels" (Brandl et al., 1997) . Such gels have been shown to consist of uni-to oligolamellar bilayer-vesicles in tight packing and to act as a diffusion barrier for incorporated drug compounds (Tardi et al., 1998) . In contrast, in the PAMPAmodel, the phospholipid is applied as a solution in organic solvent , which eventually forms monolayers, bilayers or multiple layers at the interface to the water phase.
Thompson et al (Thompson et al., 1980) have done studies that strongly indicate that a single bilayer is present per pore. In contrast Avdeef et al (Avdeef et al., 2001 ) reports multilamellar bilayers forming inside the filter channels. Wohnsland and Faller (Wohnsland and Faller, 2001 ) have been working with a system with only organic solvent in a filter support which strongly indicate solvent filled filter pores. A recent observation by Nielsen and Avdeef, that excess inert solvent with phospholipid increases the apparent porosity of the PAMPA model , also seems to point towards a coherent solvent phase both on top of the filter and in the pores. Despite all incertainty on the morphologies there appears to be a distinct difference between the two models, which may have implications in terms of partitioning and permeation of drug compounds.
Choice of drug compounds for the validation of the model
The drug compounds used to validate the present model were chosen from several different therapeutic areas. The diversity in chemical structures was large, which made the drug compounds cover a wide range of physicochemical properties (the structures of the compounds are given in Figure 1 in the Supplementary material and some of their physicochemical properties are given in Table 1 ). There are acidic and basic, as well as ampholytic and non-proteolytic drugs among the chosen compounds, to encompass both negatively, positively and non-charged compounds at pH 7.4. The compounds differ in size (mw 138 -398) and log D values (-3.00 -1.38), and were chosen to cover a wide range of absorbed fraction in humans after oral administration (F a 13 -100 %). The majority of the compounds has been reported to cross the intestinal epithelia mainly by passive diffusion, and as they are commonly studied and their permeability values in different models are available in the literature they were considered useful for comparison. However, some of the compounds are known to be substrates for carrier or efflux proteins; e.g. enalapril has been shown to be a substrate for the intestinal oligopeptide carrier PEPT1 (Amidon and Lee, 1994) and salicylic acid and acetylsalicylic acid are substrates for the monocarboxylic acid carrier (Stenberg et al., 2000) . Cimetidine and ranitidine are known to be substrates for the efflux protein p-glycoprotein (Chan et al., 2004) . Table 2 ). None of the tested markers showed a rate greater than 0.04 %/h. cm/sec to 0.015±0.001 × 10 -6 cm/sec and the mean resistance was increased from 525 to 819 Ω × cm 2 (n=3). This confirmed our expectation that the resistance was increasing with increasing centrifugation time and that the permeability of compounds like calcein is decreasing with increasing resistance.
Permeation studies with drug compounds
Permeation studies were performed for 5 hr for most compounds, but for some compounds (see 2.4) the permeation time was prolonged to 12 hr. Tests with both short and long permeation time periods were run for enalapril to verify that the obtained permeation value was independent of the duration of the permeation experiment (results not shown). The prolonged permeation time for cimetidine, nadolol, chlorothiazide and hydrochlorothiazide was done because the amount of the different drugs in the acceptor chambers after the original permeation time was too low to be detected by the analytical method used. Another approach, in cases when drug candidates show too low or no UV absorbance, is to extend the method by using LC-MS or radio-labeled drug compounds, but such methods will probably not be as appropriate for high throughput screening, and use of radio labeling would in addition be more complicated due to the safety precautions. We therefore chose to extend the permeation time rather than to use other more sensitive techniques.
The experiments were performed at least in triplicate with six inserts in each parallel for every compound. By the approach presented here, it was possible to obtain steady-state permeation values for all the 21 drug compounds used. A mean value for the apparent permeability coefficient (P app ) was calculated for each drug (see Table 3 ). As can be seen from Figure 5A , for the vast majority of drugs studied the P app obtained using the phospholipid vesicle based barrier showed a typical sigmoidal correlation with the fraction absorbed in humans after oral administration. The same shape of correlation curve had been observed also with other comparable models for permeation studies. Within our test set, there are two clear outliers, a) salicylic acid, which have been shown to be actively transported in vivo (Stenberg et al., 2000) and b) tranexamic acid, which deviates from the rest of the drug compounds by being an ampholyte (which also has low UV-absorbance). Also in other studies in the literature tranexamic acid deviates in permeability compared to other drugs with the same fraction absorbed in vivo . The apparent permeability coefficients (P app ) obtained by studying the permeation of the 21 drug compounds were compared with PSA and experimental log D, and literature data from alternative permeation models such as ILC, the Caco-2 model and the PAMPA models (Table 1 and 3) . Table 3 These models were chosen for comparison partly because of their popularity in industry and academia for screening of permeability properties of drug compounds, and partly because of their similarity to the present model. PAMPA and Caco-2 models have a similar experimental set-up and ILC and the PAMPA model make use of phospholipids to mimic the in vivo epithelial barrier. The correlation plots between the calculated properties and permeability values and percent absorbed in vivo in humans for the different models are given in Figure 4 and 5. in vivo absorption ability. The four drugs, for which the P app values did not lead to correct classification, were tranexamic acid, sulphasalazine, amiloride and salicylic acid (see Table 3 for P app values). On the other hand the compounds that are not correctly classified are found in the neighbouring class to the correct one (see Figure 6 ), for instance amiloride that is reported to be well absorbed in vivo in humans is classified as moderately absorbed according to the present model. None of the five compounds was classified completely wrong e.g. being poorly absorbed in humans and excellently absorbed according to our model or the opposite. Values for polar surface area (PSA) were also plotted against fraction absorbed in humans after oral administration (Figure 4) . By using the suggested classification from Zhu et al that PSA values less than 120 Å 2 may suggest good absorption, 50 % of the drug would be correctly classified.
The results obtained by Österberg et al ) using ILC showed poor correlation with the fraction absorbed in human after oral administration, and no attempts to divide the drugs into classes had been done.
The permeation values obtained from PAMPA models taken from the literature differ to a large extent between laboratories. It is also more difficult to categorize the permeability values obtained from PAMPA into classes of poor, moderately and well absorbed drugs, as can be done with the present model. Stronger correlation between permeability values and percent drug absorbed in human after oral administration has been achieved with PAMPA models using double sink conditions (DS-PAMPA), i.e. to control the sink conditions by the use of both a pH-gradient between the donor and acceptor chamber and a chemical scavenger system present in the acceptor compartment .
Yazdanian et al stated that compounds with a P app -value in Caco-2-cell s lower than 0.4 × 10 -6 cm/sec exhibited poor oral absorption whereas compounds with P app -value higher than 7 × 10 -6 cm/sec had excellent oral absorption. But permeation values obtained from the Caco-2 model in different laboratories often differ from each other due to use of cell lines of different origin (Artursson et al., 1996) . For a critical review of the Caco-2 model see Ungell (Ungell, 2004) . 
The unstirred water layer
Diffusion across an artificial membrane consists of two parts; diffusion through the membrane and diffusion through the so-called unstirred water layer (UWL). If the thickness of the ULW is much larger than the membrane, this part can become rate limiting for diffusion of lipophilic drugs (Kansy et al., 2004) . If this phenomenon is not taken into count, absorption parameters can be underestimated. The absorption of highly permeable drugs, such as testosterone, in in vitro permeability assays has been shown to depend on the stirring conditions (Karlsson and Artursson, 1991) . So, when not compensate for the UWL effect when using an unstirred permeability assay, the permeability of the lipophilic compounds in the UWL could significantly contribute to the resulting permeability values. The in vivo UWL is thought to be 30-100 μm thick, consistent with very efficient mixing at the surface of the gastrointestinal tract (Lennernas, 1998) . In the Caco-2 model the thickness of the aqueous boundary layer for testosterone has been reported to be about 1550 μm without any agitation (Karlsson and Artursson, 1991) and in the PAMPA model the thickness of the UWL for desipramine has been reported to be 1227 μm with no agitation . The thickness of the UWL for testosterone was reported to be 220 μm in a Caco-2 model at a shaking speed of 150 rpm (Adson et al., 1995) , and for desipramine the thickness was reported to be 73 μm in a PAMPA model with a stirring speed of 182 rpm . Our model has shown to withstand shaking at 200 rpm without disturbances of the liposome membrane in terms of resistance (results not shown). More research has to be done to see if an extension with shaking of this first simple model would lead to a more efficient approach, better reproducibility or different permeability values for the highly permeable drugs controlled mainly by the membrane.
Mass balance
Mass balance determinations were performed for metoprolol, ranitidine and sulpiride. The membrane retention in a PAMPA model with 20 % (w/v) soy lecithin with sink conditions in the acceptor wells was reported to be 26 % for metoprolol and 14 % for ranitidine at pH 7.4 ). With our model the membrane retention was found to be 11.4 % for metoprolol, while practically no retention was observed for ranitidine and sulpiride. Our membrane consists of tightly packed liposomes and hence the drug molecules have to overcome many interfaces/bilayers to reach the acceptor compartment. In contrast, in the PAMPA model the membrane consists of a much thicker, coherent lipophilic phase, which may lead to a higher degree of retention of drug molecules inside of the membrane. Some PAMPA models use surfactants in the acceptor phase to obtain sink conditions and to minimize the retention. Our assay is performed under steady-state conditions, so the data used to calculate the permeability are not affected by any membrane saturation. This taken together with the fact that since sink conditions already are obtained and the mass balance satisfactory, use of surfactants is not requested in our model.
Conclusions
We have managed to make a tight barrier of liposomes on a filter support suitable for measurement of passive drug permeability. This novel method is to our knowledge the first where one has succeeded in depositing membrane barriers without use of inert solvents such shaking to reduce the UWL. In conclusion, the phospholipid vesicle based membrane method described in this study is a very promising approach for future medium throughput screening of permeability properties of potential drug candidates early in the development process.
The 21 drugs along with their concentrations of stock solutions and the wavelengths of UV analysis are listed in Table A and the molecular structures for the drug compounds used in this study are given in Figure A . The development of the method to produce membranes is also described in detail in this section. The correlations of the permeability values from the present model as well as the existing permeability models compared with presented with log scale is given in Figure B . Supplementary material is available at http://www.sciencedirect.com. Figure 4 A comparison of correlation plots for PSA and experimental log D and extent of absorption in humans of orally administered drugs. Figure A , Supporting Information. b The log D and PSA values were taken from c The pKa values were obtained from the reference Absorption and Drug Development; Solubility, Permeability and Charge State ) except those marked with * . They were taken from d Fraction absorbed in humans after oral administration. For data are taken from 1 ; 2 ; (Kansy et al., 1998) 3 ; (Sugano et al., 2002) 4 ; 5 ; 6 ; 7 ; 8 ; 9 and 10 e The range of values reported in literature for fraction absorbed in humans is quite broad for some of the compounds. The Fa value chosen to use were mostly taken from the same articles as the permeability values for the models to compare with Values represent the resistance of the lipid barrier at the end of the transport study. The permeation values are the mean of three parallels with six insert in each. SD is given in paranthese b ILC data were taken from ) Standard deviations were not reported there c For comparison with the PAMPA model literature data from two different approaches have been used, Bio-mimetic PAMPA ) and DS-PAMPA 1 2 3 (Ruell et al., 2004) 4 . Standard deviations were not reported for the last one. d Caco-2-cell permeation data were taken from e The P app values are given in 10 -6 cm/sec f Yazdanian et al used radiochemical method of analysis while present and PAMPA studies were based on UV spectrophotometry.
